Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Malaria | 17 | 2024 | 1226 | 2.950 |
Why?
|
Maternal Health Services | 10 | 2023 | 460 | 2.750 |
Why?
|
Antimalarials | 9 | 2024 | 907 | 2.050 |
Why?
|
Artemisinins | 6 | 2016 | 218 | 2.010 |
Why?
|
Health Facilities | 7 | 2021 | 578 | 1.900 |
Why?
|
Postnatal Care | 6 | 2024 | 260 | 1.890 |
Why?
|
Delivery, Obstetric | 7 | 2024 | 939 | 1.670 |
Why?
|
Patient Acceptance of Health Care | 7 | 2021 | 3196 | 1.650 |
Why?
|
Prenatal Care | 6 | 2024 | 1140 | 1.330 |
Why?
|
Uganda | 13 | 2022 | 1332 | 1.190 |
Why?
|
Quality of Health Care | 8 | 2023 | 4325 | 1.150 |
Why?
|
Medicaid | 9 | 2022 | 2814 | 1.140 |
Why?
|
Kenya | 10 | 2023 | 757 | 1.130 |
Why?
|
Postpartum Period | 9 | 2024 | 1178 | 1.040 |
Why?
|
Obstetrics | 3 | 2021 | 666 | 1.010 |
Why?
|
Pregnancy | 34 | 2024 | 29869 | 1.000 |
Why?
|
Premature Birth | 5 | 2024 | 1782 | 0.960 |
Why?
|
Family Characteristics | 3 | 2020 | 992 | 0.920 |
Why?
|
Ethanolamines | 2 | 2016 | 153 | 0.890 |
Why?
|
Fluorenes | 2 | 2016 | 157 | 0.840 |
Why?
|
Perinatal Mortality | 2 | 2021 | 101 | 0.820 |
Why?
|
Child Mortality | 1 | 2024 | 199 | 0.810 |
Why?
|
Contraceptives, Oral, Combined | 1 | 2022 | 116 | 0.740 |
Why?
|
Fever | 3 | 2024 | 1618 | 0.730 |
Why?
|
Insurance Coverage | 4 | 2021 | 1937 | 0.730 |
Why?
|
Midwifery | 2 | 2019 | 125 | 0.710 |
Why?
|
Pregnancy, Unplanned | 1 | 2021 | 85 | 0.700 |
Why?
|
Zea mays | 1 | 2020 | 110 | 0.700 |
Why?
|
Absenteeism | 1 | 2021 | 247 | 0.680 |
Why?
|
Hospitals, Maternity | 1 | 2019 | 33 | 0.660 |
Why?
|
Reagent Kits, Diagnostic | 3 | 2017 | 239 | 0.660 |
Why?
|
Birth Intervals | 1 | 2019 | 51 | 0.650 |
Why?
|
Cost Sharing | 2 | 2019 | 409 | 0.650 |
Why?
|
Health Expenditures | 5 | 2021 | 2363 | 0.640 |
Why?
|
Dietary Proteins | 2 | 2020 | 951 | 0.610 |
Why?
|
Rural Population | 6 | 2022 | 2277 | 0.610 |
Why?
|
Primary Health Care | 4 | 2024 | 4677 | 0.600 |
Why?
|
Pregnant Women | 3 | 2021 | 567 | 0.590 |
Why?
|
Tanzania | 10 | 2024 | 1390 | 0.580 |
Why?
|
Lighting | 1 | 2019 | 211 | 0.570 |
Why?
|
Poverty | 6 | 2021 | 2692 | 0.570 |
Why?
|
Financing, Government | 4 | 2019 | 472 | 0.570 |
Why?
|
Public Assistance | 1 | 2017 | 46 | 0.560 |
Why?
|
Patient Protection and Affordable Care Act | 3 | 2021 | 1187 | 0.520 |
Why?
|
Infant, Newborn | 16 | 2024 | 26183 | 0.510 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2019 | 385 | 0.510 |
Why?
|
Infant Mortality | 1 | 2020 | 751 | 0.510 |
Why?
|
Female | 62 | 2024 | 392203 | 0.510 |
Why?
|
Rural Health Services | 1 | 2019 | 384 | 0.510 |
Why?
|
Dust | 1 | 2018 | 487 | 0.490 |
Why?
|
Pharmacies | 2 | 2013 | 167 | 0.470 |
Why?
|
Reimbursement, Incentive | 1 | 2019 | 542 | 0.450 |
Why?
|
Contraception | 3 | 2022 | 347 | 0.450 |
Why?
|
Perception | 2 | 2019 | 1199 | 0.440 |
Why?
|
Health Services Accessibility | 10 | 2023 | 5430 | 0.440 |
Why?
|
Developing Countries | 5 | 2022 | 2868 | 0.440 |
Why?
|
Drug Prescriptions | 2 | 2022 | 1669 | 0.430 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2017 | 4010 | 0.430 |
Why?
|
Nutritional Status | 2 | 2020 | 1597 | 0.420 |
Why?
|
Cesarean Section | 2 | 2024 | 1396 | 0.420 |
Why?
|
Health Personnel | 4 | 2023 | 3333 | 0.410 |
Why?
|
Cross-Sectional Studies | 14 | 2024 | 26065 | 0.410 |
Why?
|
Insurance, Health | 3 | 2021 | 2495 | 0.410 |
Why?
|
Humans | 77 | 2024 | 760740 | 0.390 |
Why?
|
Delivery of Health Care | 2 | 2020 | 5334 | 0.390 |
Why?
|
Colonoscopy | 1 | 2019 | 1397 | 0.380 |
Why?
|
Food Supply | 1 | 2017 | 539 | 0.370 |
Why?
|
Referral and Consultation | 3 | 2019 | 3599 | 0.370 |
Why?
|
Diagnostic Tests, Routine | 3 | 2024 | 786 | 0.370 |
Why?
|
Maternal Exposure | 1 | 2018 | 1067 | 0.360 |
Why?
|
Contraceptive Agents | 2 | 2022 | 144 | 0.360 |
Why?
|
South Carolina | 2 | 2021 | 100 | 0.350 |
Why?
|
Mothers | 2 | 2020 | 2194 | 0.340 |
Why?
|
Immunization Programs | 2 | 2024 | 267 | 0.340 |
Why?
|
Senegal | 2 | 2021 | 255 | 0.340 |
Why?
|
Africa South of the Sahara | 2 | 2024 | 745 | 0.340 |
Why?
|
Adult | 33 | 2024 | 220995 | 0.340 |
Why?
|
Patient Admission | 1 | 2017 | 1365 | 0.330 |
Why?
|
Patient Education as Topic | 2 | 2016 | 2315 | 0.330 |
Why?
|
Nepal | 2 | 2021 | 304 | 0.330 |
Why?
|
Child, Preschool | 14 | 2024 | 42193 | 0.320 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3196 | 0.320 |
Why?
|
Haiti | 2 | 2021 | 550 | 0.310 |
Why?
|
Pandemics | 3 | 2023 | 8652 | 0.290 |
Why?
|
Cost-Benefit Analysis | 5 | 2024 | 5493 | 0.280 |
Why?
|
Infant Care | 2 | 2020 | 180 | 0.280 |
Why?
|
Anti-Bacterial Agents | 3 | 2024 | 7403 | 0.280 |
Why?
|
Public Sector | 2 | 2021 | 264 | 0.280 |
Why?
|
Growth Disorders | 3 | 2022 | 634 | 0.270 |
Why?
|
United States | 14 | 2022 | 72292 | 0.270 |
Why?
|
Public Health | 1 | 2019 | 2671 | 0.260 |
Why?
|
Maine | 3 | 2021 | 146 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2518 | 0.250 |
Why?
|
Bipolar Disorder | 1 | 2022 | 5091 | 0.250 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6927 | 0.240 |
Why?
|
Papillomavirus Vaccines | 2 | 2021 | 496 | 0.240 |
Why?
|
Betamethasone | 1 | 2024 | 49 | 0.240 |
Why?
|
Ethiopia | 3 | 2022 | 460 | 0.230 |
Why?
|
Hospitals | 3 | 2023 | 3879 | 0.230 |
Why?
|
Private Sector | 3 | 2020 | 394 | 0.230 |
Why?
|
Healthcare Disparities | 2 | 2017 | 3351 | 0.230 |
Why?
|
Electricity | 2 | 2022 | 175 | 0.230 |
Why?
|
Medication Adherence | 1 | 2016 | 2175 | 0.230 |
Why?
|
Malaria, Falciparum | 1 | 2012 | 1076 | 0.220 |
Why?
|
Male | 27 | 2024 | 360402 | 0.210 |
Why?
|
Socioeconomic Factors | 5 | 2021 | 7805 | 0.210 |
Why?
|
Disabled Persons | 2 | 2023 | 1226 | 0.210 |
Why?
|
Infant | 9 | 2024 | 36157 | 0.200 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2948 | 0.200 |
Why?
|
Patient Compliance | 1 | 2012 | 2688 | 0.190 |
Why?
|
Democratic Republic of the Congo | 1 | 2021 | 86 | 0.190 |
Why?
|
Afghanistan | 1 | 2021 | 77 | 0.190 |
Why?
|
Ghana | 2 | 2019 | 315 | 0.180 |
Why?
|
Young Adult | 12 | 2022 | 59191 | 0.180 |
Why?
|
Cognition | 1 | 2018 | 6988 | 0.180 |
Why?
|
China | 4 | 2023 | 2374 | 0.180 |
Why?
|
Appointments and Schedules | 1 | 2024 | 442 | 0.170 |
Why?
|
Indonesia | 2 | 2017 | 128 | 0.170 |
Why?
|
Program Evaluation | 2 | 2020 | 2486 | 0.170 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2019 | 56 | 0.160 |
Why?
|
Parturition | 2 | 2022 | 447 | 0.160 |
Why?
|
Zimbabwe | 1 | 2019 | 135 | 0.160 |
Why?
|
Nigeria | 2 | 2019 | 772 | 0.160 |
Why?
|
Postpartum Hemorrhage | 1 | 2022 | 272 | 0.160 |
Why?
|
Gestational Age | 2 | 2024 | 3577 | 0.160 |
Why?
|
Malawi | 1 | 2019 | 302 | 0.160 |
Why?
|
Maternal Age | 1 | 2021 | 809 | 0.160 |
Why?
|
Steroids | 1 | 2024 | 928 | 0.160 |
Why?
|
Adolescent | 12 | 2024 | 88247 | 0.160 |
Why?
|
Contraception Behavior | 1 | 2020 | 180 | 0.150 |
Why?
|
Drug Costs | 2 | 2019 | 1183 | 0.150 |
Why?
|
Job Satisfaction | 1 | 2022 | 544 | 0.150 |
Why?
|
Mathematical Concepts | 1 | 2018 | 73 | 0.150 |
Why?
|
Drug Combinations | 2 | 2016 | 2048 | 0.150 |
Why?
|
Child | 10 | 2024 | 80089 | 0.150 |
Why?
|
Bankruptcy | 1 | 2017 | 26 | 0.140 |
Why?
|
Marketing | 1 | 2019 | 220 | 0.140 |
Why?
|
Personnel, Hospital | 1 | 2019 | 285 | 0.140 |
Why?
|
Drug Resistance, Bacterial | 1 | 2024 | 1049 | 0.140 |
Why?
|
Prealbumin | 1 | 2018 | 222 | 0.140 |
Why?
|
Intention | 1 | 2020 | 346 | 0.140 |
Why?
|
Weather | 1 | 2018 | 231 | 0.140 |
Why?
|
Attitude of Health Personnel | 2 | 2023 | 3882 | 0.140 |
Why?
|
Sex Education | 1 | 2016 | 93 | 0.130 |
Why?
|
Vaccines | 2 | 2024 | 838 | 0.130 |
Why?
|
Nutrition Disorders | 1 | 2017 | 204 | 0.130 |
Why?
|
Bacterial Infections | 1 | 2024 | 1389 | 0.130 |
Why?
|
Urbanization | 1 | 2016 | 100 | 0.130 |
Why?
|
Health Services | 1 | 2021 | 751 | 0.130 |
Why?
|
HIV Infections | 2 | 2019 | 17342 | 0.130 |
Why?
|
Breast Neoplasms | 2 | 2022 | 20988 | 0.130 |
Why?
|
Cohort Studies | 4 | 2022 | 41464 | 0.120 |
Why?
|
Pregnancy in Adolescence | 1 | 2016 | 163 | 0.120 |
Why?
|
Models, Economic | 1 | 2019 | 714 | 0.120 |
Why?
|
Drug Therapy, Combination | 3 | 2013 | 6305 | 0.120 |
Why?
|
Qualitative Research | 3 | 2020 | 3017 | 0.120 |
Why?
|
House Calls | 1 | 2016 | 161 | 0.120 |
Why?
|
Conservation of Natural Resources | 1 | 2016 | 208 | 0.120 |
Why?
|
Diabetes, Gestational | 1 | 2024 | 1250 | 0.120 |
Why?
|
Diagnostic Self Evaluation | 1 | 2016 | 225 | 0.120 |
Why?
|
Prescription Drugs | 1 | 2021 | 631 | 0.110 |
Why?
|
Physician's Role | 1 | 2020 | 917 | 0.110 |
Why?
|
Maternal Mortality | 1 | 2016 | 301 | 0.110 |
Why?
|
Interviews as Topic | 2 | 2020 | 2697 | 0.110 |
Why?
|
Focus Groups | 2 | 2017 | 1409 | 0.110 |
Why?
|
Emergencies | 1 | 2019 | 1217 | 0.100 |
Why?
|
Linear Models | 2 | 2021 | 5866 | 0.100 |
Why?
|
Telephone | 1 | 2016 | 626 | 0.100 |
Why?
|
Amino Acids | 1 | 2018 | 1718 | 0.100 |
Why?
|
Counseling | 1 | 2020 | 1538 | 0.100 |
Why?
|
Random Allocation | 2 | 2018 | 2392 | 0.100 |
Why?
|
Urban Population | 1 | 2020 | 2034 | 0.100 |
Why?
|
Economic Competition | 1 | 2013 | 219 | 0.100 |
Why?
|
Choice Behavior | 1 | 2017 | 825 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2018 | 2358 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10203 | 0.090 |
Why?
|
Geography | 1 | 2013 | 652 | 0.090 |
Why?
|
New Hampshire | 2 | 2021 | 175 | 0.090 |
Why?
|
Fear | 1 | 2020 | 1477 | 0.090 |
Why?
|
Energy Intake | 1 | 2018 | 2133 | 0.090 |
Why?
|
Pilot Projects | 3 | 2023 | 8619 | 0.090 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2012 | 219 | 0.090 |
Why?
|
Motivation | 2 | 2017 | 2003 | 0.090 |
Why?
|
Accreditation | 1 | 2013 | 473 | 0.090 |
Why?
|
Pregnancy Outcome | 1 | 2021 | 2921 | 0.090 |
Why?
|
Lactones | 1 | 2012 | 316 | 0.090 |
Why?
|
Caregivers | 1 | 2022 | 2241 | 0.080 |
Why?
|
Prevalence | 4 | 2023 | 15702 | 0.080 |
Why?
|
Chronic Disease | 1 | 2024 | 9310 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12966 | 0.080 |
Why?
|
Checklist | 1 | 2016 | 827 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2164 | 0.080 |
Why?
|
Health Policy | 1 | 2021 | 2682 | 0.080 |
Why?
|
Sexual Behavior | 1 | 2018 | 2187 | 0.080 |
Why?
|
Mental Health | 1 | 2022 | 3253 | 0.070 |
Why?
|
Breast Feeding | 1 | 2016 | 1355 | 0.070 |
Why?
|
Cost of Illness | 1 | 2017 | 1937 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3533 | 0.070 |
Why?
|
Regression Analysis | 1 | 2017 | 6339 | 0.070 |
Why?
|
Insurance Claim Review | 2 | 2021 | 741 | 0.070 |
Why?
|
India | 2 | 2024 | 2286 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20077 | 0.070 |
Why?
|
Middle Aged | 6 | 2022 | 220603 | 0.060 |
Why?
|
Health Services Needs and Demand | 1 | 2013 | 1400 | 0.060 |
Why?
|
Vaccination | 3 | 2024 | 3370 | 0.060 |
Why?
|
Stress, Psychological | 1 | 2021 | 4488 | 0.060 |
Why?
|
General Surgery | 1 | 2016 | 1692 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14599 | 0.060 |
Why?
|
Time Factors | 2 | 2017 | 39908 | 0.060 |
Why?
|
Quality Improvement | 1 | 2020 | 3801 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9644 | 0.060 |
Why?
|
Communicable Disease Control | 1 | 2010 | 846 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4845 | 0.060 |
Why?
|
Risk Factors | 2 | 2021 | 74128 | 0.060 |
Why?
|
Massachusetts | 3 | 2021 | 8835 | 0.060 |
Why?
|
Models, Statistical | 1 | 2018 | 5074 | 0.050 |
Why?
|
Immunization Schedule | 1 | 2024 | 227 | 0.050 |
Why?
|
Government | 1 | 2023 | 160 | 0.050 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2024 | 233 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5838 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2012 | 2218 | 0.050 |
Why?
|
Mass Screening | 1 | 2018 | 5425 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2012 | 1740 | 0.050 |
Why?
|
Medicare | 1 | 2019 | 6774 | 0.050 |
Why?
|
Hypertension | 1 | 2021 | 8532 | 0.050 |
Why?
|
Diet | 1 | 2018 | 8049 | 0.040 |
Why?
|
Health Care Costs | 1 | 2012 | 3238 | 0.040 |
Why?
|
Inservice Training | 1 | 2020 | 375 | 0.040 |
Why?
|
Policy | 1 | 2021 | 506 | 0.030 |
Why?
|
Clinical Protocols | 1 | 2022 | 1436 | 0.030 |
Why?
|
Advisory Committees | 1 | 2021 | 787 | 0.030 |
Why?
|
Tryptophan | 1 | 2018 | 482 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2020 | 797 | 0.030 |
Why?
|
Fees and Charges | 1 | 2016 | 192 | 0.030 |
Why?
|
Glucocorticoids | 1 | 2024 | 2160 | 0.030 |
Why?
|
Financing, Personal | 1 | 2017 | 308 | 0.030 |
Why?
|
Infant, Premature | 1 | 2024 | 2107 | 0.030 |
Why?
|
Government Programs | 1 | 2016 | 278 | 0.030 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1149 | 0.030 |
Why?
|
South Africa | 1 | 2018 | 1843 | 0.030 |
Why?
|
Monte Carlo Method | 1 | 2018 | 1257 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2017 | 991 | 0.020 |
Why?
|
Mauritius | 1 | 2010 | 2 | 0.020 |
Why?
|
HIV | 1 | 2018 | 1580 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3415 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2018 | 1932 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2018 | 2703 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2012 | 39062 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2017 | 64572 | 0.020 |
Why?
|
Self Report | 1 | 2021 | 3727 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2020 | 3451 | 0.020 |
Why?
|
Aged | 1 | 2019 | 169092 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2016 | 2092 | 0.020 |
Why?
|
Demography | 1 | 2010 | 1643 | 0.020 |
Why?
|
Cost Savings | 1 | 2010 | 912 | 0.020 |
Why?
|
Computer Simulation | 1 | 2018 | 6233 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4849 | 0.010 |
Why?
|
Decision Making | 1 | 2017 | 3919 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2020 | 80583 | 0.010 |
Why?
|
Concepts
(259)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_